Business Description
Cambium Bio Limited is an Australian clinical-stage company working to develop biological treatments for eye conditions and tissue repair. Its lead product, Elate Ocular, targets dry eye disease, while Progenza uses stem cell technology to address knee osteoarthritis and related conditions. The company also has Sygenus in development for wound healing. Cambium Bio operates from its base in Bella Vista, Australia.
